Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Past 7 days
    • Any time
    • Past hour
    • Past 24 hours
    • Past 30 days
  • Most recent
    • Best match

News

The Lancet5d
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
Copyright: © 2016 Elsevier Ltd. All rights reserved.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Appeals court blocks ruling
Israeli airstrikes hit Iran
House OKs funding cuts
Judge declares mistrial
Iran's chief of staff killed?
Deploys over 5,000 troops
On Greenland invasion plans
Flight rolls off runway
Extends WH picnic invite
Arkansas families file suit
Judge orders release
Hundreds of workers rehired
Former MTV VJ dies at 52
CIA releases more RFK files
Invests $14.3B in Scale AI
Federal land sale proposal
Air India plane crashes
SC Rep. RJ May charged
US restricts staff in Israel
IAEA declares Iran in breach
San Antonio flash floods
JetZero to build plant in NC
Rules for girl with epilepsy
Weekly jobless claims steady
Helicopter training incident
Dem governors testify
Padilla forcibly removed
Russia hits Kharkiv
Found guilty in trial
To attend security meeting
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy